Literature DB >> 34089108

ASO Author Reflections: Standardizing HIPEC Methodology and Regimens: a Prelude to the PSOGI Expert Consensus.

Aditi Bhatt1, Kurt Van Der Speeten2, Martin Hubner3, Shigeki Kusamura4, Olivier Glehen5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34089108     DOI： 10.1245/s10434-021-10205-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

2.  Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.

Authors:  Matthew K Stein; Forrest W Williard; Joanne Xiu; Miriam W Tsao; Michael G Martin; Benjamin W Deschner; Paxton V Dickson; Evan S Glazer; Danny Yakoub; David Shibata; Axel F Grothey; Philip A Philip; Jimmy J Hwang; Anthony F Shields; John L Marshall; W Michael Korn; Heinz-Josef Lenz; Jeremiah L Deneve
Journal:  J Surg Oncol       Date:  2020-03-12       Impact factor: 3.454

3.  HIPEC Methodology and Regimens: The Need for an Expert Consensus.

Authors:  Aditi Bhatt; Ignace de Hingh; Kurt Van Der Speeten; Martin Hubner; Marcello Deraco; Naoual Bakrin; Laurent Villeneuve; Shigeki Kusamura; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2021-06-17       Impact factor: 5.344

4.  Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.

Authors:  Konstantinos I Votanopoulos; Andrea Mazzocchi; Hemamylammal Sivakumar; Steven Forsythe; Julio Aleman; Edward A Levine; Aleksander Skardal
Journal:  Ann Surg Oncol       Date:  2018-11-09       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.